Iberogast (Milk Thistle Fruit Extract, Bitter Candytuft Fresh Plant Extract, Matricaria Liquid Extract, Menthae)

Iberogast contains a blend of herbal extracts that act on gastrointestinal smooth muscle and mucosa. The combination provides spasmolytic, anti‑inflammatory and pro‑kinetic effects by modulating calcium channels, muscarinic receptors and prostaglandin pathways, which together reduce muscle spasms and improve gut motility.

The dosage of Iberogast is determined by the prescribing healthcare professional based on the individual’s condition, age and response. Patients should follow the prescriber’s instructions and the product label for the recommended amount and frequency.

Safety of Iberogast in pregnancy and lactation has not been established. Women who are pregnant, planning to become pregnant or are breastfeeding should discuss potential risks and benefits with their healthcare provider before using the product.

To order Iberogast, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Unlike single‑active‑ingredient drugs, Iberogast is a multi‑component herbal formulation offering combined spasmolytic, anti‑inflammatory and pro‑kinetic actions. It may be chosen when a broader, natural‑based approach is preferred, whereas conventional agents often target a single mechanism such as acid suppression or antispasmodic activity.

Iberogast should be stored at ambient temperature, below 25 °C, in its original container. Keep the bottle tightly closed, protect it from moisture and direct sunlight, and keep it out of reach of children.

Iberogast is supplied as liquid oral drops. The prescribed dose is measured with the provided dropper and taken by mouth, usually before or after meals as directed by the prescriber. It should not be mixed with other liquids unless instructed.

Serious risks, though rare, include allergic reactions such as rash, swelling or anaphylaxis, and potential liver injury manifested by elevated liver enzymes or hepatitis. Patients should discontinue use and seek medical attention if they experience any signs of severe allergy or liver dysfunction.

Iberogast should be avoided in individuals with known hypersensitivity to any of its herbal components, in patients with severe liver disease, and in those for whom safety during pregnancy or lactation has not been established unless advised otherwise by a healthcare professional.